CD274 and neoplasm: By blocking the PD-1/PD-L1 signaling pathway, T cells can be intensively activated to recognize and kill tumor cells, resulting in the effective inhibition of tumor growth, causing PD-L1 to become a promising target of tumor immunotherapy.